Video Latest - ecancer

Systems perspectives of the exposome

Dr Paolo Vineis - Imperial College, London, UK

30 Jun 2016

Tackling cancer in the developing world

Dr Christopher Wild - Director of IARC, Lyon, France

29 Jun 2016

Editor's Choice for June 2016

Prof Gordon McVie - ecancer Editor in Chief

29 Jun 2016

Latest in precision cancer medicine

Prof Richard Schilsky - Chief Medical Officer, ASCO

15 Jun 2016

Advances in first line treatment options for MCL patients

Professor Steven Le Gouill and Professor Simon Rule

11 Jun 2016

The latest in CLL from EHA 2016

Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam

11 Jun 2016

An overview of MCL from EHA 2016

Professor Simon Rule and Professor Steven Le Gouill

10 Jun 2016

ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer?

Prof Charles Ryan and Prof Nick James

6 Jun 2016

Global drug pricing: How cost-effective is bevacizumab?

Dr Daniel Goldstein - Emory University, Atlanta, USA

6 Jun 2016

Update on olaparib in ovarian cancer

Prof Jonathan Ledermann - University College Hospital Medical School, London, UK

6 Jun 2016

Impact of precision medicine in refractory malignancies

Prof Maria Schwaederle - University of California, San Diego, USA

$Impact of precision medicine in refractory malignancies ( Prof Maria Schwaederle - University of California, San Diego, USA )$

6 Jun 2016

Photon vs proton beam therapy: modality in radiotherapy for non-small cell lung cancer

Dr Madhusmita Behera - Emory University, Atlanta, USA

6 Jun 2016

Video